Erratum: Novel high-affinity EGFRvIII-specific chimeric antigen receptor T cells effectively eliminate human glioblastoma

Clin Transl Immunology. 2021 Jul 18;10(7):e1317. doi: 10.1002/cti2.1317. eCollection 2021.

Authors

Rebecca C Abbott, Daniel J Verdon, Fiona M Gracey, Hannah E Hughes-Parry, Melinda Iliopoulos, Katherine A Watson, Matthias Mulazzani, Kylie Luong, Colleen D'Arcy, Lucy C Sullivan, Ben R Kiefel, Ryan S Cross, Misty R Jenkins

Abstract

[This corrects the article DOI: 10.1002/cti2.1283.].

© 2021 The Authors. Clinical & Translational Immunology published by John Wiley & Sons Australia, Ltd on behalf of Australian and New Zealand Society for Immunology Inc.

Publication types

Published Erratum